<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9206865</journal-id>
<journal-id journal-id-type="pubmed-jr-id">25587</journal-id>
<journal-id journal-id-type="nlm-ta">J Genet Couns</journal-id>
<journal-id journal-id-type="iso-abbrev">J Genet Couns</journal-id>
<journal-title-group>
<journal-title>Journal of genetic counseling</journal-title>
</journal-title-group>
<issn pub-type="ppub">1059-7700</issn>
<issn pub-type="epub">1573-3599</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30964584</article-id>
<article-id pub-id-type="pmc">7385984</article-id>
<article-id pub-id-type="doi">10.1002/jgc4.1119</article-id>
<article-id pub-id-type="manuscript">NIHMS1602986</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Toolkit for Genetics Providers in Follow-up of Patients with Non-Diagnostic Exome Sequencing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zastrow</surname>
<given-names>Diane B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kohler</surname>
<given-names>Jennefer N.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonner</surname>
<given-names>Devon</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reuter</surname>
<given-names>Chloe M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fernandez</surname>
<given-names>Liliana</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grove</surname>
<given-names>Megan E.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fisk</surname>
<given-names>Dianna G.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<collab>Undiagnosed Diseases Network</collab>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Yaping</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eng</surname>
<given-names>Christine M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ward</surname>
<given-names>Patricia A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bick</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Worthey</surname>
<given-names>Elizabeth A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fisher</surname>
<given-names>Paul G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ashley</surname>
<given-names>Euan A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernstein</surname>
<given-names>Jonathan A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wheeler</surname>
<given-names>Matthew T.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Center for Undiagnosed Diseases, Stanford University, Stanford, CA</aff>
<aff id="A2"><label>2</label>Clinical Genomics Program, Stanford Health Care, Stanford, CA</aff>
<aff id="A3"><label>3</label>Baylor College of Medicine, Houston, TX</aff>
<aff id="A4"><label>4</label>HudsonAlpha Institute for Biotechnology, Huntsville, AL</aff>
<aff id="A5"><label>5</label>Department of Neurology, Stanford University School of Medicine, Stanford, CA</aff>
<aff id="A6"><label>6</label>Department of Pediatrics, Stanford University School of Medicine, Stanford, CA</aff>
<aff id="A7"><label>7</label>Department of Genetics, Stanford University School of Medicine, Stanford, CA</aff>
<aff id="A8"><label>8</label>Department of Medicine, Stanford University School of Medicine, Stanford, CA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1"><bold>Authorship Contributions</bold> Diane B. Zastrow, Jennefer Kohler, Devon Bonner, Chloe Reuter, Jonathan A. Bernstein and Matthew T. Wheeler: Substantial contributions to the conception or design of the work; Drafting the work or revising it critically for important intellectual content; Final approval of the version to be published; Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
<p id="P2">Megan Grove, Dianna Fisk, Liliana Fernandez, Paul G. Fisher, Euan A. Ashley, Yaping Yang, Christine M. Eng, Patricia A. Ward, David Bick, Elizabeth A. Worthey: Drafting the work or revising it critically for important intellectual content; Final approval of the version to be published; Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
</fn>
<corresp id="CR1">Corresponding Authors: <email>dzastrow@stanford.edu</email>, <email>wheelerm@stanford.edu</email>, Diane B. Zastrow, Stanford Center for Undiagnosed Diseases, 780 Welch Rd. CJ250H, Stanford, CA 94304, Phone (650) 725-7254, fax (650) 498-8882, Matthew T. Wheeler, Assistant Professor of Medicine, Division of Cardiovascular Medicine, Center for Undiagnosed Diseases, Stanford University, 870 Quarry Rd MC 5406, Palo Alto, CA 94304, Phone (650) 725-5921, fax (650) 725 1599</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P52"><bold>Conflict of interest</bold> Diane B. Zastrow, Devon Bonner, Chloe Reuter, Jennefer N. Kohler, Liliana Fernandez, Megan E. Grove, Dianna G. Fisk, Yaping Yang, Christine M. Eng, Patricia A. Ward, David Bick, and Elizabeth A. Worthey declare that they have no conflict of interest. Euan A. Ashley is a founder and member of the scientific advisory board of Personalis and Deepcell. Euan A. Ashley is an advisor to Genome Medical and Sequencebio. Matthew T. Wheeler has a minor ownership interest in Personalis.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>28</volume>
<issue>2</issue>
<fpage>213</fpage>
<lpage>228</lpage>
<!--elocation-id from pubmed: 10.1002/jgc4.1119-->
<abstract id="ABS1">
<p id="P3">There are approximately 7,000 rare diseases affecting 25–30 million Americans, with 80% estimated to have a genetic basis. This presents a challenge for genetics practitioners to determine appropriate testing, make accurate diagnoses, and conduct up-to-date patient management. Exome sequencing is a comprehensive diagnostic approach, but only 25–41% of patients receive a molecular diagnosis. The remaining three-fifths to three-quarters of patients undergoing exome sequencing remain undiagnosed. The Stanford Center for Undiagnosed Diseases (CUD), a clinical site of the Undiagnosed Diseases Network, evaluates patients with undiagnosed and rare diseases using a combination of methods including exome sequencing. Frequently these patients have non-diagnostic exome sequencing results, but strategic follow up techniques identify diagnoses in a subset. We present techniques used at the CUD that can be adopted by genetics providers in clinical follow-up of cases where exome sequencing is non-diagnostic. Solved case examples illustrate different types of non-diagnostic results and the additional techniques that led to a diagnosis. Frequent approaches include segregation analysis, data reanalysis, genome sequencing, additional variant identification, careful phenotype-disease correlation, confirmatory testing, and case matching. We also discuss prioritization of cases for additional analyses.</p>
</abstract>
<kwd-group>
<kwd>Exome sequencing</kwd>
<kwd>genome sequencing</kwd>
<kwd>undiagnosed diseases</kwd>
<kwd>sequencing reanalysis</kwd>
<kwd>rare diseases</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>